Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TR115 in Relapsed/Refractory Peripheral T/NK-Cell Lymphoma
NCT07639879Phase 3Not yet recruiting
- Sponsor
- Tarapeutics Science Inc
- Start
- Jul 2026
- Primary completion
- Jul 2029
- Countries
- 1
01
Overview
A Phase 3 trial of TR115 in peripheral T-cell lymphoma (PTCL), Natural killer T-cell lymphoma (NKTL), sponsored by Tarapeutics Science Inc. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
TR115
03
Conditions
peripheral T-cell lymphoma (PTCL)Natural killer T-cell lymphoma (NKTL)
Beyond the preview
Go deeper on NCT07639879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07639879.